ArticleRenal failure2025
Exploring the comorbidity mechanisms of ITGB2 in rheumatoid arthritis and membranous nephropathy through integrated bioinformatics analysis.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with rheumatoid arthritis (RA) are more likely to comorbid renal diseases, with membranous nephropathy (MN) being the most common. This study aimed to explore the common pathogenesis between RA and MN using integrated bioinformatics analysis.
methodsBulk and single-cell RNA sequencing datasets were obtained from the Gene Expression Omnibus and ImmPort databases. Differential expressed genes (DEGs) were identified and enrichment analysis was performed. Topology analysis and the random forest algorithm were applied to identify hub genes. The single-sample Gene Set Enrichment Analysis method was used to assess immune infiltration. Single-cell RNA sequencing analysis was employed to compare the transcript levels of key gene across different cell types. Pseudotime analysis was conducted using Monocle3, and cellular communication was analyzed with CellChat. The L1000FWD database was used to identify potential drugs, and molecular docking was performed.
results66 common upregulated DEGs were identified, primarily associated with leukocyte migration and the chemokine signaling pathway. ITGB2 was finally identified as the shared pathogenic gene of both RA and MN. ITGB2 was predominantly expressed in macrophages, and its expression increased as M0 macrophages differentiated into M1 macrophages. BAFF signaling between macrophages with high ITGB2 expression and B cells/plasma cells was enhanced. Small molecules targeting ITGB2, including LY-294002 and CP466722, may serve as potential drugs for both RA and MN.
conclusionAs the pathogenic gene shared by both RA and MN, ITGB2 may play a role in M1 macrophage polarization and contribute to the maturation and differentiation of B cells through BAFF signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.